首页> 外国专利> VARIANTS OF GROUP I ALLEGATIONS FROM POACEAE WITH REDUCED ALLEGATIONS AND CONTINUED T-cell reactivity

VARIANTS OF GROUP I ALLEGATIONS FROM POACEAE WITH REDUCED ALLEGATIONS AND CONTINUED T-cell reactivity

机译:减少的指控和持续的T细胞反应性来自禾本科的第I组指控的变种

摘要

Variants (A) of group 1 allergens (I) of Poaceae that have, compared with the wild-type allergens, reduced immunoglobulin E (IgE) reactivitiy but essentially retained reactivity with T lymphocytes, are new. Independent claims are also included for: (1) DNA molecules (II) that encode (A); (2) recombinant expression vector (EV) containing (II) functionally linked to an expression control sequence; (3) host organism transformed with (II) or EV; and (4) preparing (A) by growing organisms of (3). ACTIVITY : Antiallergic. MECHANISM OF ACTION : Vaccine; Immunotherapy; Hyposensitization.
机译:与野生型变应原相比,禾本科第1组变应原(I)的变体(A)具有较弱的免疫球蛋白E(IgE)反应性,但基本上保留了与T淋巴细胞的反应性。还包括以下方面的独立权利要求:(1)编码(A)的DNA分子(II); (2)重组表达载体(EV),其含有与表达控制序列功能性连接的(II)。 (3)用(II)或EV转化的宿主生物; (4)通过生长(3)的生物制备(A)。活动:抗过敏。作用机理:疫苗;免疫疗法低敏化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号